Literature DB >> 19371575

Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement.

Jia Qi1, Jing-Yu Yang, Fang Wang, Ya-Nan Zhao, Ming Song, Chun-Fu Wu.   

Abstract

Accumulating evidence has shown the neuroactive properties of oxytocin (OT), a neurohypophyseal neuropeptide, and its ability to reduce the abuse potential of drugs. The present study investigated the effects of OT on the conditioned place preference (CPP) induced by methamphetamine (MAP, 2.0 mg/kg, i.p.) in mice and the possible role of glutamatergic neurotransmission in the reinstatement of CPP. The results showed that OT (0.1, 0.5, 2.5 microg, i.c.v.) significantly inhibited the acquisition and facilitated the extinction of MAP-induced CPP and abolished the reinstatement of CPP induced by restraint stress. This effect of OT could be attenuated by atosiban (Ato, 2.0 microg, i.c.v.), a selective OT-receptor antagonist. OT failed to block the expression and the reinstatement of CPP induced by MAP challenge. Extracellular glutamate (Glu) levels in the medial prefrontal cortex (mPFC) were determined using microdialysis coupled to a high-performance liquid chromatography (HPLC) with a fluorescence detection system. The results indicated that OT markedly inhibited extracellular Glu levels induced by restraint stress in CPP mice, but not those induced by MAP priming. Ato also attenuated the effects of OT on the changes in Glu levels. Therefore, these findings suggest that OT inhibits drug reward-related behaviors induced by MAP via the OT receptor, and OT blocks the reinstatement of CPP, at least partially, by interfering with the glutamatergic system in the mPFC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371575     DOI: 10.1016/j.neuropharm.2009.01.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  50 in total

Review 1.  Inhibitory role of oxytocin in psychostimulant-induced psychological dependence and its effects on dopaminergic and glutaminergic transmission.

Authors:  Jing-yu Yang; Jia Qi; Wen-yan Han; Fang Wang; Chun-fu Wu
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

2.  Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions.

Authors:  Siri Leknes; Johan Wessberg; Dan-Mikael Ellingsen; Olga Chelnokova; Håkan Olausson; Bruno Laeng
Journal:  Soc Cogn Affect Neurosci       Date:  2012-05-29       Impact factor: 3.436

3.  The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.

Authors:  Panos Zanos; Polymnia Georgiou; Sherie R Wright; Susanna M Hourani; Ian Kitchen; Raphaëlle Winsky-Sommerer; Alexis Bailey
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

4.  Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers.

Authors:  Kathryne Van Hedger; Anya K Bershad; Royce Lee; Harriet de Wit
Journal:  Nicotine Tob Res       Date:  2020-01-27       Impact factor: 4.244

5.  The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats.

Authors:  Cassandra O Subiah; Musa V Mabandla; Alisa Phulukdaree; Anil A Chuturgoon; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2012-03-25       Impact factor: 3.584

Review 6.  Coming full circle: contributions of central and peripheral oxytocin actions to energy balance.

Authors:  Jacqueline M Ho; James E Blevins
Journal:  Endocrinology       Date:  2012-12-27       Impact factor: 4.736

7.  Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats.

Authors:  Sara Sabihi; Nicole E Durosko; Shirley M Dong; Benedetta Leuner
Journal:  Psychoneuroendocrinology       Date:  2014-03-29       Impact factor: 4.905

8.  Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study.

Authors:  Melissa A Miller; Anya Bershad; Andrea C King; Royce Lee; Harriet de Wit
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

9.  Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.

Authors:  Shannon J Clough; Anthony J Hutchinson; Randall L Hudson; Margarita L Dubocovich
Journal:  Physiol Behav       Date:  2014-05-09

10.  Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice.

Authors:  Xue Xue; Jing-Yu Yang; Yi He; Li-Rong Wang; Ping Liu; Li-Sha Yu; Guo-Hua Bi; Ming-Ming Zhu; Yue-Yang Liu; Rong-Wu Xiang; Xiao-Ting Yang; Xin-Yu Fan; Xiao-Min Wang; Jia Qi; Hong-Jie Zhang; Tuo Wei; Wei Cui; Guang-Lu Ge; Zheng-Xiong Xi; Chun-Fu Wu; Xing-Jie Liang
Journal:  Nat Nanotechnol       Date:  2016-03-14       Impact factor: 39.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.